Prudential Financial Portfolio holdings
AUM
$77.4B
1-Year Return
21.48%
This Quarter Return
+8.83%
1 Year Return
+21.48%
3 Year Return
+96.22%
5 Year Return
+175.48%
10 Year Return
+394.71%
AUM
$72.8B
AUM Growth
+$5.98B
(+8.9%)
Cap. Flow
+$810M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
21.66%
Holding
2,668
New
184
Increased
967
Reduced
1,382
Closed
122
Top Buys
| 1 |
Exxon Mobil
XOM
|
$183M |
| 2 |
Lam Research
LRCX
|
$162M |
| 3 |
Coca-Cola
KO
|
$153M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$149M |
| 5 |
Starbucks
SBUX
|
$139M |
Top Sells
| 1 |
Financial Select Sector SPDR Fund
XLF
|
$487M |
| 2 |
Merck
MRK
|
$199M |
| 3 |
eBay
EBAY
|
$172M |
| 4 |
Procter & Gamble
PG
|
$151M |
| 5 |
Cisco
CSCO
|
$149M |
Sector Composition
| 1 | Technology | 21.82% |
| 2 | Healthcare | 12.32% |
| 3 | Financials | 12.28% |
| 4 | Consumer Discretionary | 10.79% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Kosmos Energy
KOS
$784M
| $89K | ﹤0.01% |
25,625
+260
| +1% | +$903 |
|
2502
Globalstar
GSAT
$3.96B
| $83K | ﹤0.01% |
3,119
+2,452
| +368% | +$65.3K |
|
2503
Akebia Therapeutics
AKBA
$785M
| $80K | ﹤0.01% |
21,041
+2,655
| +14% | +$10.1K |
|
|
AGEN
2504
Agenus
AGEN
$138M
| $77K | ﹤0.01% |
713
+144
| +25% | +$15.6K |
|
2505
MindMed
MNMD
$702M
| $75K | ﹤0.01% |
+1,443
| New | +$75K |
|
2506
Cerus
CERS
$255M
| $73K | ﹤0.01% |
12,298
-1,070
| -8% | -$6.35K |
|
|
VBIV
2507
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $72K | ﹤0.01% |
712
+370
| +108% | +$37.4K |
|
|
IDEX
2508
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $70K | ﹤0.01% |
+196
| New | +$70K |
|
2509
Clear Channel Outdoor Holdings
CCO
$656M
| $69K | ﹤0.01% |
+26,240
| New | +$69K |
|
|
NEX
2510
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $64K | ﹤0.01% |
13,476
+300
| +2% | +$1.43K |
|
2511
Kezar Life Sciences
KZR
$29.8M
| $61K | ﹤0.01% |
1,137
-2,089
| -65% | -$112K |
|
2512
VirnetX
VHC
$78.5M
| $57K | ﹤0.01% |
664
+92
| +16% | +$7.9K |
|
2513
Accuray
ARAY
$170M
| $55K | ﹤0.01% |
12,134
+210
| +2% | +$952 |
|
|
BDSI
2514
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $54K | ﹤0.01% |
15,115
+2,678
| +22% | +$9.57K |
|
2515
Comscore
SCOR
$32.1M
| $52K | ﹤0.01% |
+525
| New | +$52K |
|
|
XXII
2516
22nd Century Group
XXII
$6.47M
| – | – |
0
| – | – |
|
2517
Rigel Pharmaceuticals
RIGL
$742M
| $50K | ﹤0.01% |
1,161
+46
| +4% | +$1.98K |
|
2518
Carisma Therapeutics
CARM
$16.8M
| $49K | ﹤0.01% |
+536
| New | +$49K |
|
2519
Verastem
VSTM
$663M
| $49K | ﹤0.01% |
1,000
-1,524
| -60% | -$74.7K |
|
2520
Banco Santander
SAN
$141B
| $47K | ﹤0.01% |
+12,027
| New | +$47K |
|
|
ASXC
2521
DELISTED
Asensus Surgical, Inc.
ASXC
| $47K | ﹤0.01% |
+14,900
| New | +$47K |
|
|
KDMN
2522
DELISTED
Kadmon Holdings, Inc.
KDMN
| $44K | ﹤0.01% |
11,440
+500
| +5% | +$1.92K |
|
2523
Mustang Bio
MBIO
$10.4M
| $42K | ﹤0.01% |
+17
| New | +$42K |
|
2524
Alaunos Therapeutics
TCRT
$4.27M
| $42K | ﹤0.01% |
107
+1
| +0.9% | +$393 |
|
2525
Uranium Energy
UEC
$4.96B
| $42K | ﹤0.01% |
15,740
+1,000
| +7% | +$2.67K |
|